JNJ vs PFE · P/E 17, rev $49.37B vs P/E 20, rev $15.03B
Johnson & Johnson (JNJ) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla D.V.M., Ph.D..
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported PFE revenue for 2026-06-28 was $15.03B. Net income was -$248.0M. Revenue was up 4.0% from 2026-03-29 to 2026-06-28. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the JNJ and PFE stock pages for the full models.
Not investment advice.